These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 16621522
1. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J. J Steroid Biochem Mol Biol; 2006 Jun; 99(4-5):182-8. PubMed ID: 16621522 [Abstract] [Full Text] [Related]
2. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies? Kalogera E, Pistos C, Provatopoulou X, Athanaselis S, Spiliopoulou C, Gounaris A. J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec 01; 940():24-34. PubMed ID: 24140653 [Abstract] [Full Text] [Related]
3. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Labrie F, Bélanger A, Cusan L, Candas B. J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2403-9. PubMed ID: 9253308 [Abstract] [Full Text] [Related]
4. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B. J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2396-402. PubMed ID: 9253307 [Abstract] [Full Text] [Related]
5. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks. Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L, Vaillancourt M, Montesino M, Balser J, Moyneur É, other participating members of the Prasterone Clinical Research Group. J Steroid Biochem Mol Biol; 2016 May 01; 159():142-53. PubMed ID: 26972555 [Abstract] [Full Text] [Related]
6. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. Bélanger A, Brochu M, Cliche J. J Clin Endocrinol Metab; 1986 May 01; 62(5):812-5. PubMed ID: 2937801 [Abstract] [Full Text] [Related]
7. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women. Labrie F, Bélanger A, Labrie C, Candas B, Cusan L, Gomez JL. J Steroid Biochem Mol Biol; 2007 Oct 01; 107(1-2):57-69. PubMed ID: 17627814 [Abstract] [Full Text] [Related]
8. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women. Stanczyk FZ, Saxena T, Lobo RA. J Steroid Biochem Mol Biol; 2014 Jan 01; 139():73-7. PubMed ID: 24121067 [Abstract] [Full Text] [Related]
9. Metabolism of DHEA in postmenopausal women following percutaneous administration. Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J. J Steroid Biochem Mol Biol; 2007 Feb 01; 103(2):178-88. PubMed ID: 17084625 [Abstract] [Full Text] [Related]
10. Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Oh H, Wild RA, Manson JE, Bea JW, Shadyab AH, Pfeiffer RM, Saquib N, Underland L, Anderson GL, Xu X, Trabert B. Cancer Epidemiol Biomarkers Prev; 2021 Nov 01; 30(11):2018-2029. PubMed ID: 34446472 [Abstract] [Full Text] [Related]
11. Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Trabert B, Michels KA, Anderson GL, Brinton LA, Falk RT, Geczik AM, Harris HR, Pan K, Pfeiffer RM, Qi L, Rohan T, Wentzensen N, Xu X. Int J Cancer; 2019 Oct 15; 145(8):2051-2060. PubMed ID: 30684389 [Abstract] [Full Text] [Related]
12. Is there a correlation between androgens and sexual desire in women? Wåhlin-Jacobsen S, Pedersen AT, Kristensen E, Laessøe NC, Lundqvist M, Cohen AS, Hougaard DM, Giraldi A. J Sex Med; 2015 Feb 15; 12(2):358-73. PubMed ID: 25475395 [Abstract] [Full Text] [Related]
13. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens. Labrie F, Martel C, Bérubé R, Côté I, Labrie C, Cusan L, Gomez JL. J Steroid Biochem Mol Biol; 2013 Nov 15; 138():359-67. PubMed ID: 23954500 [Abstract] [Full Text] [Related]
14. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration. Ke Y, Labrie F, Gonthier R, Simard JN, Bergeron D, Martel C, Vaillancourt M, Montesino M, Lavoie L, Archer DF, Balser J, Moyneur E, other participating Members of the Prasterone Clinical Research Group. J Steroid Biochem Mol Biol; 2015 Nov 15; 154():186-96. PubMed ID: 26291918 [Abstract] [Full Text] [Related]
15. Evaluation of urinary excretion of androgens conjugated to cysteine in human pregnancy by mass spectrometry. Fabregat A, Marcos J, Garrostas L, Segura J, Pozo OJ, Ventura R. J Steroid Biochem Mol Biol; 2014 Jan 15; 139():192-200. PubMed ID: 23410595 [Abstract] [Full Text] [Related]
16. Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. Vandenput L, Labrie F, Mellström D, Swanson C, Knutsson T, Peeker R, Ljunggren O, Orwoll E, Eriksson AL, Damber JE, Ohlsson C. J Bone Miner Res; 2007 Feb 15; 22(2):220-7. PubMed ID: 17059374 [Abstract] [Full Text] [Related]
17. Role of androgens in women's sexual dysfunction. Basson R, Brotto LA, Petkau AJ, Labrie F. Menopause; 2010 Feb 15; 17(5):962-71. PubMed ID: 20539247 [Abstract] [Full Text] [Related]
18. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. Labrie F, Cusan L, Gomez JL, Martel C, Bérubé R, Bélanger P, Chaussade V, Deloche C, Leclaire J. J Steroid Biochem Mol Biol; 2008 May 15; 110(1-2):1-9. PubMed ID: 18359622 [Abstract] [Full Text] [Related]
19. Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA. Ke Y, Gonthier R, Simard JN, Archer D, Lavoie L, Martel C, Vaillancourt M, Labrie F. Horm Mol Biol Clin Investig; 2015 Dec 15; 24(3):117-29. PubMed ID: 26509785 [Abstract] [Full Text] [Related]
20. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer. Stanczyk FZ, Azen CG, Pike MC. J Steroid Biochem Mol Biol; 2013 Nov 15; 138():10-6. PubMed ID: 23474436 [Abstract] [Full Text] [Related] Page: [Next] [New Search]